ImmuneOnco Biopharmaceuticals has received approval from China’s National Medical Products Administration for a Phase II ...

The recently published article in Science by the Genentech team presents the structure of CD20 in complex with the therapeutic monoclonal antibody RTX. This study underscores the significance of ...

All 20 assets are trading higher. Leaders: RENDER (+13.5%) and ETC (+11.3%). Laggards: BTC (+2.4%) and ETH (+2.6%). The <a ...

Avalanche, the layer-1 blockchain that is upgrading its technology platform, has raised $250 million in a token sale led by ...

Adding the humanized CD19-targeted monoclonal antibody tafasitamab (Monjuvi) to a backbone of lenalidomide (Revlimid) and ...

The non-cryopreserved CD19- and CD20-directed CAR T-cell therapy zamto-cel is manufactured in a closed-system device that ...

In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid manufactured anti-CD19/CD20 CAR T-cell ...

The CoinDesk 20 is currently trading at 3830.63, down 0.2% (-7.76) since 4 p.m. ET on Thursday. Six of 20 assets are trading ...

Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...

With a median follow-up of 14.1 months, adding tafasitamab to lenalidomide and rituximab reduced the risk of progression, ...

The data published shows that IPH6501, also called CD20-NKCE-IL2v in the publication, boosts NK cell proliferation and cytotoxicity, showing activity against a range of B-NHL cell lines ...